Valuation AstraZeneca PLC BOERSE MUENCHEN

Stocks

Real-time BOERSE MUENCHEN Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-1.26%

07-17	Nordic stocks in North America - Astra Zeneca fell 0.3%	FW
07-16	Illumina, Inc., Formation Bio, Astrazeneca, Merck, and Eli Lilly and Company Expand Billion Cell Atlas Alliance with New Ai Drug Developers	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	262,792	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-8.69%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	281,987	274,695	266,276
Change	-	12.57%	-0.25%	-1.74%	36.64%	-9.38%	-2.59%	-3.06%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21.2x	18.6x	16.1x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.96x	4.31x	3.64x
PEG	-	0x	0.4x	1.6x	0.6x	0.9x	1.3x	1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.16x	3.93x	3.7x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.46x	4.11x	3.74x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.3x	11x	9.73x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.3x	11.7x	10.4x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	28.1x	20.8x	18.2x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.56%	4.81%	5.5%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.341	3.522	3.657
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.97%	2.08%	2.16%
EPS ²	0.08	2.11	3.81	4.5	6.54	8.007	9.124	10.55
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.7%	38.6%	34.7%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,212	66,788	71,111
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,854	24,923	27,376
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,136	23,391	25,689
Net income ¹	112	3,288	5,961	7,035	10,225	12,432	13,937	15,996
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,195	11,903	3,484
Reference price ²	117.51	135.16	135.02	131.05	185.60	169.43	169.43	169.43
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.75x	12.42x	25.87x	0.58%	1,043B
JOHNSON & JOHNSON	26.86x	6.13x	16.78x	2.15%	602B
ABBVIE INC.	33.14x	7.52x	15.43x	2.7%	449B
ROCHE HOLDING AG	17.71x	4.39x	10.82x	3.02%	327B
NOVARTIS AG	21.31x	5.47x	13.24x	2.89%	279B
AMGEN INC.	24.37x	6.42x	11.35x	2.71%	201B
GILEAD SCIENCES, INC.	-49.1x	5.86x	32.41x	2.38%	169B
PFIZER INC.	12.77x	3.12x	7.88x	6.86%	143B
VERTEX PHARMACEUTICALS INCORPORATED	27.8x	8.4x	18.93x	-.--%	123B
Average	16.62x	6.64x	16.97x	2.59%	370.71B
Weighted average by Cap.	24.24x	8.02x	18.72x	2.05%